Lars Plate
-
New collaborative research project seeks improved treatment for cystic fibrosis
Lars Plate, assistant professor of chemistry and biological sciences, has received a $2.76 million collaborative grant to investigate medical therapy for people with cystic fibrosis. The interdisciplinary project brings together teams with varied expertise in computational structural biology, proteomics, biophysics, and physiology in hopes of improving the quality of life for those afflicted with the genetic disease. Read MoreNov 16, 2023
-
Annual Vanderbilt Institute of Chemical Biology Symposium is Aug. 8
The 2023 annual Vanderbilt Institute of Chemical Biology Symposium, featuring prominent scientists—including keynote speaker Dr. John Yates III—will be Aug. 8 at the Student Life Center. Sponsored by Ancora Innovation, the event will include discussions on innovative life science research and drug development, promising a day of knowledge sharing and networking for Vanderbilt students, staff and faculty. Read MoreJul 6, 2023
-
Lars Plate wins Scialog Award from the Research Corporation for Science Advancement and USDA
For his work on zoonotic threat mitigation, Lars Plate was awarded $50,000 from the Research Corporation for Science Advancement and the U.S. Department of Agriculture. Read MoreJan 17, 2023
-
Vanderbilt scientist’s team project wins $55,000 to research fundamental cell behavior
Lars Plate wins $55,000 from Scialog to further collaborative research on cell behavior. Read MoreJan 6, 2022
-
Class of 2021: Undergraduate research inspires future physician-scientist to bridge the bedside and the bench
When Mason Clark was in middle school, his beloved grandmother suffered a serious heart attack. She survived, thanks to the help of the local hospital, and the experience led Clark to his life’s purpose. Read MoreApr 16, 2021
-
Newly discovered molecule disrupts virus infections through protein quality control pathways
Molecule 147 neutralizes 95 percent of Dengue and Zika viruses, a promising direction for host-directed treatments and combination therapy. Read MoreJan 26, 2021
-
To understand how SARS-CoV-2 replicates, Vanderbilt scientists look at host cell-virus interactions
Understanding the function of host cells when infected with SARS-CoV-2 may lead to host-directed antiviral therapeutics. Read MoreDec 7, 2020